Physician profile
Stanley Chen
NPI 1992480743
$425.15
in general payments reported to CMS, 2019-2025
10 companies · $146 in 2025
The $146 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $279 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $425.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $425.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $119.68 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $54.73 | 2024-2025 | Hyqvia |
| Genentech USA, INC. | $49.33 | 2024-2025 | Ocrevus Zunovo, Ocrevus, Enspryng |
| Sk Life Science, INC. | $42.49 | 2025 | Xcopri |
| Ucb, INC. | $38.49 | 2025 | Rystiggo |
| Neurelis, INC. | $38.40 | 2024 | Valtoco |
| Mdd US Operations, LLC | $24.67 | 2024 | Apokyn |
| Gilead Sciences, INC. | $23.47 | 2024 | |
| Eisai INC. | $19.62 | 2024 | |
| Lundbeck LLC | $14.27 | 2025 | Vyepti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stanley Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.